- Home
- TGTX
TGTX
TG Therapeutics Inc.
as 05-09-2025 4:00pm EST
| Founded: | 1993 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | 1995 |
| Target Price: | $40.80 | AVG Volume (30 days): | 3.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.24 | EPS Growth: | -14.74 |
| 52 Week Low/High: | $15.16 - $46.48 | Next Earning Date: | 05-05-2025 |
| Revenue: | $386,386,000 | Revenue Growth: | 33.54% |
| Revenue Growth (this year): | 75.6% | Revenue Growth (next year): | 38.25% |
Latest TG Therapeutics Inc. News
TGTX Breaking Stock News: Dive into TGTX Ticker-Specific Updates for Smart Investing
Insider Monkey
2 days ago
TG Therapeutics, Inc. (TGTX): Among the Best Cancer Stocks to Invest in for Long-Term Gain
Argus Research
5 days ago
TGTX: Lowering target price to $37.00
Simply Wall St.
5 days ago
TG Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
GuruFocus.com
5 days ago
TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Strong BRIUMVI Sales and Increased ...
Thomson Reuters StreetEvents
6 days ago
Q1 2025 TG Therapeutics Inc Earnings Call
Motley Fool
6 days ago
Why TG Therapeutics Stock Was Tumbling Today
Zacks
6 days ago
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates
MT Newswires
6 days ago
TG Therapeutics' Q1 Swings to Net Income, Revenue Rises; Full-Year 2025 BRIUMVI Revenue Guidance Updated
Compare TGTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TGTX TG Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.